Brief: Bellerophon Provides Clinical Program Update And Reports Second Quarter 2020 Financial Results

Bellerophon Therapeutics

05/08/2020 13:34

Bellerophon Therapeutics Inc  BLPH.O :
    * BELLEROPHON PROVIDES CLINICAL PROGRAM UPDATE AND REPORTS
SECOND
QUARTER 2020 FINANCIAL RESULTS
    * Q2 LOSS PER SHARE $0.51
    * Q2 EARNINGS PER SHARE ESTIMATE $-0.72 -- REFINITIV IBES
DATA
    * COMPANY EXPECTS TO INITIATE REBUILD STUDY IN SECOND HALF
OF 2020
    * AS OF JUNE 30, 2020, COMPANY HAD CASH AND CASH EQUIVALENTS
OF
$59.3 MILLION

Source text for Eikon:  ID:nGNX7bMv2N 
Further company coverage:  BLPH.O